Group 1: Company Development Highlights - The installed capacity of the company reached 225.725 MW by October 2025, with approximately 50 MW under construction and another 50 MW planned [3][6] - The company achieved a renewable energy sales volume of 25.44 billion kWh in the first three quarters of 2025, saving 20.70 million tons of standard coal and reducing CO2 emissions by 53.82 million tons [3] - The company was awarded the "Best Practice Case for Sustainable Development" by the Association of Listed Companies in 2025 [3] Group 2: Future Outlook - The company plans to continue focusing on green, market-oriented, integrated, and intelligent strategies to enhance efficiency and effectiveness [5] - The National Energy Administration's recent guidelines aim to promote the integration of renewable energy, establishing a multi-level consumption and regulation system by 2030 [4] Group 3: Financial Performance - The company experienced a revenue decline of approximately 4.38 billion CNY, leading to a 25.54% year-on-year drop in revenue due to the exclusion of natural gas operations from consolidation [6] - The cash flow from operating activities reached 1.228 billion CNY in the first three quarters of 2025, a 39.21% increase year-on-year [6] Group 4: Strategic Projects - The Kunming Anning 350 MW compressed air energy storage project has a total investment of 1.87167 billion CNY and is expected to enhance the company's renewable energy ecosystem [8] - The project aims to provide grid peak regulation and facilitate large-scale integration of renewable energy [9] Group 5: Market Position and Competitive Advantage - The company benefits from favorable policies and geographical advantages, with wind power utilization hours consistently above the national average [11][12] - The financing cost is currently controlled within 3%, ensuring robust financial health [9]

编号：2025-012 | | □特定对象调研 ■分析师会议 | | | --- | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | | 类别 | □新闻发布会 □路演活动 | | | | □现场参观 | | | | □其他 | | | 参与单位名称及 | 东方财富证券：梅宇鑫；建信基金：吴昂达；汇丰基金：王家怡 | | | 人员姓名 | 鹏华基金：杨浩；中信建投自营：彭卓栋 | | | 时间 | 2025 年 11 月 日 15:30—16:00 | 21 | | 地点 | 电话会议 | | | 上市公司接待人 | 副总经理、董事会秘书：沈一涛 | | | 员姓名 | | | | | 董事会秘书沈一涛简要介绍了公司在胶粘剂与特种树脂新材料、电子 | | | | 信息材料、电子科技等领域的布局；并对控股子公司大连齐化环氧树脂 | | | | 稀释剂产能等相关情况进行介绍。 | | | | Q1:请问公司子公司大连齐化环氧稀释剂产能如何？ | | | | A：公司控股子公司大连齐化新材料有限公司的环氧树脂稀释剂（特种 | | | | 活性稀释剂）产能为 4000 吨/年（单班） ...

Financial Performance - The company's net profit for the first three quarters of 2025 increased nearly 10 times compared to the previous year, with revenue growth exceeding 51% [2] - The sales volume of the core product, cough tablets, reached 64% of the same period in 2023, while revenue recovered to 96.69% of the same period [4] Marketing and Sales Strategy - The company transitioned from a pure agency model to a hybrid model of self-operated and promotional services, which initially caused a temporary decline in performance but has since shown recovery [3] - The marketing reform initiated in 2024 has begun to yield results, contributing significantly to the performance growth in 2025 [3] Product Performance - In Q3 2025, cough tablets sold 104 million pieces, generating revenue of 69.62 million yuan [4] - The cough tablets have a clinical effectiveness rate of 73% and a total effectiveness rate of 93%, demonstrating significant therapeutic advantages [10] Market Potential - The aging population in China is projected to increase by 13 million people aged 60 and above in 2024, expanding the patient base for respiratory diseases [4] - The company has identified ample market expansion opportunities due to the previous regional agency sales model, which left many markets untapped [4] Online Sales Strategy - The company has successfully launched the brain-quieting capsules online, achieving sales of over 13 million yuan by Q3 2025 [6] - Future plans include enhancing online exposure through content marketing and expanding presence on platforms like Douyin and Xiaohongshu [6] New Product Development - The company has established an independent marketing team to promote skin disease blood detox pills and blood sugar comfort pills, leveraging existing channels from cough tablets for market entry [8] - The skin disease blood detox pill and blood sugar comfort pill are positioned as strategic products with significant market potential, supported by favorable policies and clinical research [12] Overall Strategy - The company aims to achieve annual sales of 100 million boxes of cough tablets within 3-5 years post-marketing reform [4] - The "1+N" product development strategy focuses on enhancing the core product while nurturing a portfolio of complementary products to drive long-term growth [13]

Group 1: Case Overview - The case involves Guangzhou Yihai, which was accused of being an accomplice in a contract fraud case related to Anhui Huawen and Yunnan Huijia [1][2] - The essence of the case is that Anhui Huawen, in collusion with Yunnan Huijia, engaged in fraudulent activities that led to significant losses of state assets [1][2][3] - Guangzhou Yihai claims to be the victim of deception, asserting that it was misled by Anhui Huawen's executives [1][4] Group 2: Legal Arguments - The company argues that the first-instance judgment was fundamentally flawed in its factual findings and legal application [2] - Key points include: - Anhui Huawen's losses were self-inflicted due to collusion with Yunnan Huijia, not due to any actions by Guangzhou Yihai [2] - Guangzhou Yihai maintained due diligence and complied with contractual obligations, thus not participating in any fraudulent activities [2][3] - The company did not gain any benefits from the alleged fraudulent actions [2][3] Group 3: Procedural Violations - The investigation phase was marred by intentional concealment of case information by the police [3][8] - The prosecution failed to properly inform Guangzhou Yihai of the case's status, violating its litigation rights [3][8] - The court's decision to separate trials and deny other defendants' appearances hindered the fact-finding process [3][8] Group 4: Financial Implications - The first-instance judgment imposed a compensation of 1.881 billion RMB on Guangzhou Yihai, which the company contests as baseless [9][10] - The company asserts that the judgment could have uncertain impacts on its financial performance, pending the outcome of the appeal [12] Group 5: Company’s Position and Future Actions - The company emphasizes its commitment to legal compliance and social responsibility, having invested approximately 100 billion RMB in China [4][5] - Guangzhou Yihai plans to exhaust all legal avenues to appeal the judgment and clear its name [4][11] - The company expresses confidence that the second-instance court will deliver a fair ruling [15]

Group 1: Company Overview and Strategy - The company focuses on innovation in pharmaceuticals, adhering to a strategic framework of "one body, two wings, and three depths" to enhance its core competitiveness [2][4] - It has established a complete industrial chain covering standardized planting, production, research and development, sales, and logistics [3][4] Group 2: Research and Development Progress - In 2025, the company accelerated its R&D efforts, with key products like the improved traditional Chinese medicine "Panlong Qining Gel Patch" receiving clinical trial approval [3] - The company aims to achieve a "21355" target for major product cultivation, developing a diverse product ecosystem that includes both oral and external applications [3] Group 3: Main Products and Market Position - The leading product, "Panlong Qipian," has a market share of 7.73% in the traditional Chinese medicine market for musculoskeletal diseases [6] - "Panlong Qipian" is recognized as a unique patented product and has been included in multiple national clinical guidelines and expert consensus [5][6] Group 4: Marketing and Sales Strategy - The company has built a comprehensive marketing network across 30 provincial administrative regions, collaborating with over 650 commercial partners [6] - It has expanded its reach to over 30,000 retail pharmacies and 20,000 grassroots medical units, creating a dual-channel sales strategy [6] - The digital marketing strategy has improved user lifecycle management efficiency by 40% and marketing response speed by 60% [6]

Group 1: Market Position and Product Strategy - The company has established a price range for its pickled vegetable products between 2 RMB and 12 RMB, with the 60g and 70g products accounting for approximately 50% of total revenue [2] - The B-end channel, particularly in the catering sector, has shown growth, with sales expected to exceed 20% this year, and overall B-end sales surpassing 100 million RMB [2] - The company is focusing on maintaining brand exposure through promotional activities in offline channels, including supermarket displays and targeted marketing campaigns [2] Group 2: Product Development and Innovation - New products launched this year, such as the crispy series, have generated approximately 5 million RMB in sales since May, while other new items have collectively exceeded 10 million RMB in e-commerce sales [7] - The company plans to slow down the introduction of new products next year, focusing on optimizing existing offerings and adopting a flexible, small-batch production model to meet diverse consumer demands [9] Group 3: Supply Chain and Raw Material Management - The company has established a protection price mechanism for raw materials, agreeing to purchase green vegetable heads at a minimum price of 800 RMB per ton, which encourages local farmers to cultivate these materials [5] - The construction of the China Pickled Vegetable City project is progressing, with foundational structures completed and production lines set to be updated based on market demand [6] Group 4: Mergers and Acquisitions - The company is actively seeking suitable acquisition targets within the condiment and compound seasoning sectors, with ongoing evaluations of potential candidates [3] Group 5: Sales and Marketing Strategies - The company employs a dual-channel approach for sales, utilizing both online platforms (e.g., Tmall, JD.com) and offline channels, with dedicated teams for each segment [9] - New product promotions involve online trials followed by offline sales, supported by incentives for sales personnel to boost new product visibility and consumer adoption [4]

Group 1: Company Performance - The company achieved a revenue of 4.108 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 15.00% [2] - The net profit attributable to shareholders reached 228 million yuan, with a non-recurring net profit of 232 million yuan [2] - The company’s gross margin for the latest quarter increased to 19.96% [2] Group 2: Market Expansion and Product Development - Sales in automotive electronics, smart terminals, and industrial control sectors grew by 22%, 24%, and 18% respectively [3] - The company invested 203 million yuan in R&D in the first three quarters of 2025, marking a year-on-year increase of 22.81% [3] - The company focuses on high-end product development in six key areas: high reliability, high capacity, high temperature, high voltage, high precision, and high frequency [3] Group 3: AI and Emerging Markets - The company is prioritizing AI computing as a core business direction and has established deep partnerships with leading domestic AI server clients [4] - New products developed for AI power systems include a full range of ceramic capacitors and alloy resistors designed for high efficiency and stability [4][5] - The company’s production capacity utilization rate remains high, with ongoing expansion in MLCC, chip resistors, and inductors [5] Group 4: Pricing and Investment Strategy - The company has adjusted prices for certain products in response to rising raw material costs while maintaining a long-term cooperation philosophy [6] - Recent investments include projects for high-end resistor upgrades and the addition of a new production line for high-current multilayer inductors [6] - The company has completed automotive electronic product certifications and expanded its product offerings to include critical systems in electric vehicles [6]

Group 1: Company Overview - The company was established in 1989 and listed on the Shenzhen Stock Exchange in 1997, with 35 logistics park projects in over 20 major cities across China, forming the largest wholesale market network for agricultural products in the country [1] - The average annual trading volume of the company's wholesale markets exceeds 33 million tons, with an average annual transaction value exceeding 250 billion yuan [1] - The company's business scope includes standardized base planting, cold chain processing, wholesale market construction and operation, urban ingredient distribution, brand development, and import-export trade [1] Group 2: Competitive Advantages - After 36 years of development, the company has extensive experience in operating wholesale markets and a strong management talent pool [2] - The company integrates global partner resources and provides a one-stop service for the entire agricultural product supply chain, including wholesale trading venues, food safety testing, and brand cultivation [2] Group 3: Impact of New Retail Formats - The development of online new retail formats complements and collaborates with the wholesale market, creating an efficient supply chain linkage [3] - The company is enhancing its service capabilities through digital and intelligent tools, reinforcing its role as a core hub in the supply chain [4] Group 4: Revenue Enhancement Strategies - The company aims to improve transaction efficiency in the agricultural product circulation sector by accelerating project development and optimizing market layouts [4] - It plans to expand its business around the wholesale market, including supply chain connections, ingredient distribution, and brand development [4] Group 5: Market Management and Pricing - Revenue from the company's wholesale market management primarily comes from rent, commissions, management fees, and parking fees, with pricing based on market conditions and local economic factors [4] Group 6: Network Expansion Initiatives - The company is enhancing its national network by advancing key projects and promoting multi-regional collaboration [5] - New projects are being developed in strategic areas, including Shanghai, Chengdu, and Guangzhou, while older markets may undergo relocation or upgrades [7] Group 7: Base Operations and Supply Chain - The company has established cooperative relationships with approximately 10,000 acres of planting bases across multiple provinces, focusing on high-quality product cultivation [9] - It is actively developing the "Deep Farm" initiative to integrate agricultural production with rural revitalization [9] Group 8: Urban Ingredient Distribution - The company has expanded its ingredient distribution business, establishing 21 branches in major cities and covering various regions [9] - It aims to enhance food safety management capabilities and has been recognized for its quality management [9] Group 9: Digital Transformation - The company is leveraging big data, IoT, and cloud computing to enhance its digital operations and accelerate transformation [9] - Initiatives include the implementation of a unified transaction system and the launch of a price collection and release platform to improve market transparency [9]

Group 1: Company Overview and Market Position - The beverage industry in China is currently experiencing moderate overall prosperity, but the company has performed well in recent years due to its competitive advantages [2][3] - The company has identified a growing consumer demand for healthy, natural, low-sugar, and low-calorie beverages, which has driven market growth [2][3] - As of the first half of 2025, the company's overseas revenue was approximately CNY 441 million, accounting for 46.02% of total operating income [3] Group 2: Financial Performance and Orders - The significant increase in liabilities during the third quarter of 2025 is attributed to a rise in orders on hand and an increase in advance payments [3] - The company has a sufficient backlog of orders, indicating strong future revenue potential [4] - The growth rate of contract liabilities has outpaced revenue growth due to factors such as a substantial increase in orders and longer fulfillment cycles for non-standard manufacturing [4] Group 3: International Market Strategy - The company primarily exports to Southeast Asia, India, Africa, the Americas, and Europe [4] - The international sales model mainly relies on agency sales, supplemented by direct sales in certain regions [4] - The company aims to enhance its market presence by optimizing product and customer structures and improving brand image [3][4] Group 4: Production and Automation - The company's factory expansion project is progressing steadily, with plans to gradually introduce automation while maintaining skilled labor for complex production processes [4][5] - The typical production cycle after a contract is signed is approximately 3-6 months, followed by a 2-4 month period for transportation and installation [4] Group 5: Profitability and Cost Structure - The gross margin in international markets is higher than in domestic markets due to product cost advantages and differences in market competition [5] - The company’s packaging machinery typically has an economic lifespan of around 10 years, influenced by various factors including technological advancements and market demand [5]

Group 1: Company Development Strategy - The company focuses on enhancing phosphate and fluorine chemical industries in the Yichang region, aiming to establish a comprehensive resource utilization system and a significant fluorosilicon industrial park in Central China [2] - In the Xinjiang region, the strategy emphasizes the development of coal chemical industries, leveraging local coal resources for clean and efficient conversion [2] - The Inner Mongolia and Qinghai regions will prioritize chlor-alkali chemical industries, aiming for technological advancement and improved energy efficiency [2][3] Group 2: Production Capacity and Cost Management - The company has a production capacity of 300,000 tons of iron phosphate and 200,000 tons of nickel sulfate, with production lines nearing full capacity, leading to reduced costs [3] - Chlor-alkali production capacity stands at 900,000 tons for PVC and 940,000 tons for caustic soda, with recent decreases in raw material costs improving profitability [3] - Rising sulfur prices are expected to increase production costs for phosphate ammonium, but the company will prioritize domestic fertilizer supply without affecting production loads [3]